R&D spending in Sweden by business rose an estimated 4.2% in 2008 to SEK 87,681 million ($12,498 million) in constant prices. Within the business sector, R&D investments by producers of goods accounted for 75% of spending compared to 25% for the service sector. R&D spending by the higher education sector (excluding ALF funds) also increased, […]

Israeli spending on civilian R&D rose 3.6% in constant prices last year to NIS 35.3 billion ($9.2 billion), or 4.9% of GDP. R&D expenditures by business grew 4.5% to make up 81% of the county’s total R&D spending. R&D spending by private nonprofit institutions increased 2.5% to represent 3% of the country’s R&D spending. General […]

China’s stimulus plans are accelerating growth in the R&D and technology sectors. Cong Cao of the Levin Graduate Institute of International Relations and Commerce at the State University of New York estimates that CNY 1.4 billion ($205.2 million) of the stimulus plan’s science and technology funding will be used for the country’s Medium- and Long-term […]

A new report from the Organization of Pharmaceutical Producers of India (OPPI) and Ernst & Young finds that India remains among the most attractive outsourcing locations for the biopharmaceutical industry. Excluding clinical trials, in 2010, the country is expected to account for 5.7% of the $66 billion pharmaceutical contract research and manufacturing marketing. In a […]